Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.

NCT03081832 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Oxytocin
OTHER: Control

Sponsor

University Hospital, Toulouse